KAB Biotech Holding ApS: Financial statements 2018
CVR: 37692646
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
KAB Biotech Holding ApS (CVR 37692646) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -17,000 and a net result of DKK 9,892,311 compared with DKK 457,159 the year before. Equity in the 2018 report amounted to DKK 17,152,759. The solvency ratio was 99.5%.
- Gross Profit
- DKK -17,000
- Profit/Loss
- DKK 9,892,311
- Equity
- DKK 17,152,759
- Total Assets
- DKK 17,236,759
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -17 t. | 9.9 mio. | 17.2 mio. | - |
| 2017 | - | -16 t. | 457 t. | 7.3 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
KAB Biotech Holding ApS has published its annual report for 2017. Gross profit came to DKK -15,750, and the net result was DKK 457,159.
About KAB Biotech Holding ApS
KAB Biotech Holding ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2016. The company has been dissolved on 17 August 2020. The company was registered under the industry Ikke-finansielle holdingselskaber. According to the 2019 annual report, the company had an average of 0 employees. In 2019, the company reported a gross profit of DKK -17,000 and a net result of DKK 7,466,344 compared with DKK 9,892,311 the year before. Equity in the 2019 report amounted to DKK 24,619,103.